CNXU is the official NASDAQ ticker symbol for Conexeu Sciences Inc, an early-stage medical technology and biotechnology enterprise. The company focuses on developing innovative, patented collagen-based regenerative tissue scaffold products and extracellular matrix platforms designed for applications in medical aesthetics, wound care, tissue repair, and soft-tissue volume restoration.